The share of corresponding/leading author in scientific publications in biotechnology in Canada was at a certain level in 2023, from which it is forecasted to slightly decline from 87.33 in 2024 to 86.03 by 2028. There is a gradual year-on-year decline, translating to an average compound annual growth rate (CAGR) of around -0.5% from 2024 to 2028. This subtle yet consistent decrease signals a modest shift towards a potentially more collaborative authorship model.
Future trends to observe:
- Emergence of collaborative research efforts with more international co-authors.
- Increasing interdisciplinary projects, possibly diversifying author contributions.
- Adoption of advanced research technologies enhancing publication practices.
